You have 9 free searches left this month | for more free features.

Clinical Trial, Phase II

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Common Wart Trial (KNP2002, Placebo of KNP2002)

Not yet recruiting
  • Common Wart
  • (no location specified)
May 31, 2023

Sleep Initiation and Maintenance Disorders Trial (QUALI)

No longer available
  • Sleep Initiation and Maintenance Disorders
  • (no location specified)
Feb 23, 2023

Alzheimer Trial in Houston (Interleukin-2, Placebo)

Recruiting
  • Alzheimer Disease
  • Houston, Texas
    Houston Methodist Research Institute
Oct 17, 2023

Bipolar II Disorder Trial in Dresden, Groningen (GH001)

Recruiting
  • Bipolar II Disorder
  • Dresden, Germany
  • +1 more
Apr 20, 2023

Hand, Foot and Mouth Disease, Herpangina Trial in Chuxiong (low dose Bivalent Enterovirus Vaccine (Vero Cell), Inactivated,

Recruiting
  • Hand, Foot and Mouth Disease
  • Herpangina
  • low dose Bivalent Enterovirus Vaccine (Vero Cell), Inactivated
  • +3 more
  • Chuxiong, Yunnan, China
    Dayao County Center for Disease Control and Prevention
Sep 25, 2023

Advanced Solid Tumors Trial (PE0116,PE0105)

Not yet recruiting
  • Advanced Solid Tumors
  • (no location specified)
Sep 6, 2023

Rotavirus Infections, Diarrhea Trial (IRV on a 0- and 28-day schedule, IRV on a 0-, 28- and 56-day schedule, Placebo on Day 0,

Not yet recruiting
  • Rotavirus Infections
  • Diarrhea
  • IRV on a 0- and 28-day schedule
  • +3 more
  • (no location specified)
Oct 8, 2023

NSCLC Trial (Phase I - Mirdametinib - Level 1, Phase II - Mirdametinib, Phase I - Mirdametinib - Level 2)

Not yet recruiting
  • Non-Small Cell Lung Cancer
  • Phase I - Mirdametinib - Level 1
  • +4 more
  • (no location specified)
Jul 7, 2023

Seminoma Trial in Duesseldorf (Robot-assisted retroperitoneal lymph node dissection, Adjuvant therapy with one cycle of

Recruiting
  • Seminoma
  • Robot-assisted retroperitoneal lymph node dissection
  • Adjuvant therapy with one cycle of cisplatin, etoposide and bleomycin
  • Duesseldorf, Germany
    University Hospital of Duesseldorf
Nov 17, 2023

Stage II Melanoma Trial in Wollstonecraft (Relatlimab and nivolumab fixed dose combination (FDC))

Not yet recruiting
  • Stage II Melanoma
  • Relatlimab and nivolumab fixed dose combination (FDC)
  • Wollstonecraft, New South Wales, Australia
    Melanoma Institute Australia
Oct 26, 2022

SARS-CoV-2 Trial in Nanjing (SARS-CoV-2 Bivalent mRNA Vaccine, Recombinant SARS-CoV-2 vaccine, Saline)

Not yet recruiting
  • SARS-CoV-2
  • SARS-CoV-2 Bivalent mRNA Vaccine
  • +2 more
  • Nanjing, Jiangsu, China
    Jiangsu Provincial Center for Disease Control and Prevention
Jul 7, 2023

Peritoneal Metastases, Colorectal Cancer Trial in Hangzhou (Hyperthermic intraperitoneal treatment of recombinant modified human

Recruiting
  • Peritoneal Metastases
  • Colorectal Cancer
  • Hyperthermic intraperitoneal treatment of recombinant modified human tumor necrosis factor (rmhTNF)
  • Hangzhou, Zhejiang, China
    2nd Affiliated Hospital, School of Medicine, Zhejiang University
Mar 2, 2023

COVID-19 Trial in Austin (ExoFlo)

Withdrawn
  • COVID-19
  • (no location specified)
Dec 23, 2022

Osteosarcoma Trial (Tucidinostat, Apatinib)

Not yet recruiting
  • Osteosarcoma
  • Tucidinostat, Apatinib
  • (no location specified)
Nov 5, 2023

Non-hodgkin Lymphoma Trial (HY004)

Not yet recruiting
  • Non-hodgkin Lymphoma
  • HY004
  • (no location specified)
Aug 21, 2023

Advanced Malignant Tumors Trial in China (LBL-033 for Injection)

Not yet recruiting
  • Advanced Malignant Tumors
  • LBL-033 for Injection
  • Fuzhou, Fujian, China
  • +5 more
Mar 19, 2023

Malignant Sarcoma Trial in Madrid (Natural Killer (NK) cells (a new immunotherapy))

Recruiting
  • Malignant Sarcoma
  • Natural Killer (NK) cells (a new immunotherapy)
  • Madrid, Spain
    Hospital Universitario La Paz
Jul 19, 2023

Hamstring Injury Trial in Pittsburgh (Losartan, )

Recruiting
  • Hamstring Injury
  • Pittsburgh, Pennsylvania
    University of Pittsburgh
Dec 14, 2022

Hepatic Ascites Trial in Guangdong (Recombinant Human Serum Albumin, Human serum albumin)

Not yet recruiting
  • Hepatic Ascites
  • Recombinant Human Serum Albumin
  • Human serum albumin
  • Guangdong, Shenzhen, China
    Shenzhen Protgen Ltd
May 5, 2023

Pompe Disease (Late-onset) Trial in Durham (Clenbuterol, Placebos)

Withdrawn
  • Pompe Disease (Late-onset)
  • Durham, North Carolina
    Duke University Medical Center
Aug 15, 2022

Non Small Cell Lung Cancer Trial (HLX208+HLX10)

Not yet recruiting
  • Non Small Cell Lung Cancer
  • HLX208+HLX10
  • (no location specified)
Nov 30, 2022

Hidradenitis Suppurativa Trial in Granada (Injectable suspension of allogeneic adult mesenchymal stem cells, Placebo)

Recruiting
  • Hidradenitis Suppurativa
  • Injectable suspension of allogeneic adult mesenchymal stem cells
  • Placebo
  • Granada, Spain
    Hospital Universitario Virgen de Las Nieves
Jul 6, 2023

Ventricular Tachycardia Trial in Zürich (Dose escalating stereotactic arrhythmia radioablation to treat ventricular tachycardia

Recruiting
  • Ventricular Tachycardia
  • Dose escalating stereotactic arrhythmia radioablation to treat ventricular tachycardia (VT)
  • Zürich, Zurich, Switzerland
    University Hospital Zurich
Oct 21, 2022

Amyotrophic Lateral Sclerosis Trial (Acetyl-l-carnitine, Placebo)

Not yet recruiting
  • Amyotrophic Lateral Sclerosis
  • (no location specified)
Nov 9, 2023

Overweight or Obesity Trial in Uppsala (Xenical® vs EMP 22, EMP 22 vs Xenical®, EMP 16 vs Xenical®)

Not yet recruiting
  • Overweight or Obesity
  • Xenical® vs EMP 22
  • +2 more
  • Uppsala, Sweden
    CTC Clinical Trial Consultanta AB
Aug 25, 2023